Call president Ken Shenkman, Ph.D. @ 888-295-2844 or 561-989-0808,
fax 561-989-9404, e-mail: firstname.lastname@example.org, or write 1181 So.
Rogers Circle, Suite 5, Boca Raton, FL 33487. www.newagecities.com
www.newagesound.com [R-6; M-7; L-8]
This section does not include information from all the news releases
I receive on situations I have covered in past recommen-dations
or Sneak Previews. If you hold any such stocks, please get your
news & updates at www.WallStreetCorner-.com by using "Financial
Click the "Go Search" button at the top right of the home page.
When the Financial Navigator page comes up, type in the symbol of
the company. You'll get the current price & volume, & can usually
get almost anything else you want from the pull down menus under
"News," & the other categories of information at the top of the
I usually include updates on only a few situations where I have
either personally interviewed management, believe some personal
comment by me is appropriate, or am particularly interested in the
news. I do not have room for much detail, but on each situation
I cover, I include contact information for your convenience.
AAON, Inc. (NASDAQ/AAON -- CS Sneak 10/93) is a sleeper.
It's presently selling for about 11 times trailing earnings; an
undervalued situation. Revenues for the six months ended 6/30/99
were $60,998,000 (up from $49,464,000 for the same period last year),
with net earnings of $4,185,000, or $0.65 per share (up from $2,383,000
or $0.37 per share). I suggest you look into this one. Call CFO
William Bowen @ 843-520-4835 or 918-583-2266, fax 918-382-6215,
or write 2425 South Yukon, Tulsa, OK 74107. [R-7; M-7; L-8]
A1 Internet.com, Inc. (OTC Bulletin Board/AWON -- CS 9/99)
filed its Form 10SB with the SEC -- you can view it at www.WallStreetCorner.com
using Financial Navigator, typing in AWON, & getting the file from
EDGAR. Once the form is effective, AWON will file its NASDAQ application.
Call Roseanne Farino @ 888-865-2223 or 561-218-2223, fax 561-218-0112,
e-mail -- Investorrelations@A1is.com, or write 7900 Glades Road,
Suite 435, Boca Raton, FL 33065 www.A1Internet.com [R-6; M-7; L-8]
Actrade International Ltd. (NASDAQ/ACRT -- CS Sneak 10/95
& 1/99) announced that Alexander C. Stonkus, former CFO, has been
appointed president, & Joseph P.D. Alessandris, CPA, was named CFO
-- he was international controller for Information Builders, Inc.
& director of international joint ventures & precious metal transportation
for Englehard Corp. Call Jonathan Fichman, IR, @ 732-868-3100 x205,
fax 212-563-3271, or write 7 Penn Plaza, Suite 422, New York, NY
10001. www.actrade.com. [R-8; M-7; L-8]
American Bio Medica Corp. (NASDAQ/ABMC -- CS Sneak 12/98)
moved to a new 30,000 sq. ft. facility in Kinderhook, NY to meet
its growing market demand as the #3 on-site drug testing company.
ABMC also launched a resource website at www.drugfreeschools.com
to assist schools in developing & implementing drug testing initiatives.
It posted a 63% sales increase for Q1 (7/31/99) to $ 2,127,000,
bringing it closer to profitable operations. In Q1 1998, the loss
was ($276,000). In Q1 1999, it decreased to ($27,000). On 9/16/99,
ABMC reported sales in August 1999 were $881,000, up from $476,000
in 8/98, & a 40% increase over the previous month's (7/99) sales.
Also on 9/16/99 it announced it won its Friedenberg appeal -- good
news for the bottom line. Call Melissa Decker @ 800-227-1243, fax
518-758-8171, e-mail email@example.com www.americanbiomedica.com
[R-6; M-6; L-8]
BCAM International, Inc. (OTC Bulletin Board/BCAM -- CS
5/98) acquired LungCheck, Inc., a Delaware private company. It specializes
in lung disease diagnosis & assessment of lung health. Consideration
was two classes of preferred stock, which, when converted to BCAM
common stock, would represent about 80% of the common stock outstanding
immediately after the merger.
Prior to the merger, BCAM transferred to ISTX, Inc., then a 90%
owned subsidiary of BCAM, all of the then technology holdings of
BCAM related to the Intelligence Surface Technology, Microwave Technology,
& the licensing agreements with Textron & Reebok. ISTX assumed substantially
all of the debt of BCAM.
Immediately before the merger, BCAM irrevocably transferred to
its shareholders of record 9/22/99 (did not include persons who
became shareholders as a result of the merger) its 90% interest
in ISTX on the basis of one share of ISTX for each share of BCAM
held just before the merger.
This is a "spin-off." It means ISTX will become a public company,
after it files a registration statement with the SEC & appropriate
other disclosures. This should occur within the next 90 days. In
connection with all of these steps, various parties invested about
$1.1 million -- about $250,000 of this will be transferred to ISTX
BCAM CEO Michael Strauss will manage the LungCheck business, the
sole business of BCAM as of 9/23/99 (it probably will change its
name to LungCheck). He will also be CEO of ISTX, Inc. Call CEO Michael
Strauss @ 516-752-3550, or write 1800 Walt Whitman Rd., Melville,
NY 11747. [R-7; M-7; L-8]
...continued on next page, click here